Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)

Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)

US Patent 11279771 · Granted Mar 22, 2022

Estimated economic value: $28,121,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Factor VII (FVII(a))/TREM-like transcript 1 (TLT-1) bispecific antibodies2024
Glucose-sensitive albumin-binding derivatives2023
Bispecific antibodies2022
Protein conjugates2022
Glucose-sensitive albumin-binding derivatives2021
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020